Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer

Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal therapy makes it urgent and necessary to identify novel targets for PCa treatment. Herein, dual-specificity tyrosine ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Kai, Li, Zhaoxing, Kuang, Wenbin, Wang, Xiao, Ji, Minghui, Chen, Weijiao, Ding, Jiayu, Li, Jiaxing, Min, Wenjian, Sun, Chengliang, Ye, Xiuquan, Lu, Meiling, Wang, Liping, Ge, Haixia, Jiang, Yuzhang, Hao, Haiping, Xiao, Yibei, Yang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133015/
https://www.ncbi.nlm.nih.gov/pubmed/35614066
http://dx.doi.org/10.1038/s41467-022-30581-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133015/
https://www.ncbi.nlm.nih.gov/pubmed/35614066
http://dx.doi.org/10.1038/s41467-022-30581-4

Ejemplares similares